Biopol Chemicals Financials

NSE: BIOPOL

₹44.95

₹-2.35 (-4.97%)

As on 09-Sep-2026IST

Market cap

₹49 Cr

Revenue (TTM)

₹49 Cr

P/E Ratio

5.4

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	49.13	17.43	--	--	--	--
Total Income	49.15	17.43	--	--	--	--
Total Expenditure	42.59	15.56	--	--	--	--
EBITDA	6.53	1.88	--	--	--	--
Depreciation	0.07	0.04	--	--	--	--
EBIT	6.46	1.84	--	--	--	--
Interest	0.68	0.12	--	--	--	--
Other Income	0.02	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	5.80	1.71	--	--	--	--
Provision for Tax	1.47	0.43	--	--	--	--
Profit after Tax	4.33	1.28	--	--	--	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	13.53	9.20	--	--	--	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.65	0.02	--	--	--	--
Current Liabilities	17.25	8.31	--	--	--	--
Total Liabilities	31.48	17.56	--	--	--	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	0.24	0.27	--	--	--	--
Current Assets	31.20	17.26	--	--	--	--
Total Assets	31.48	17.56	--	--	--	--
Total Debt*	7.69	3.58	--	--	--	--
Net Current Assets	13.95	8.95	--	--	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	-2.34	-8.87	--	--	--	--
Cash Flow from Investing Activities	-0.02	-0.07	--	--	--	--
Cash from Financing Activities	3.43	9.02	--	--	--	--
Net Cash Inflow / Outflow	1.07	0.08	--	--	--	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	5.47	1.62	--	--	--	--
Cash EPS (₹)	5.56	1.67	--	--	--	--
Adjusted Book Value (₹)	17.10	11.63	--	--	--	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	-2.95	-11.21	--	--	--	--
Free Cash Flow per Share (₹)	-5.09	-11.77	--	--	--	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	38.16	14.37	--	--	--	--
ROE (%)	38.10	13.92	--	--	--	--
ROA (%)	17.69	7.31	--	--	--	--
EBIT Margin (%)	13.16	10.53	--	--	--	--
Net Margin (%)	8.81	7.35	--	--	--	--
Cash Profit Margin (%)	8.96	7.58	--	--	--	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	181.82	--	--	--	--	--
EBIT Growth (%)	251.99	--	--	--	--	--
Net Profit Growth (%)	238.08	--	--	--	--	--
EPS Growth (%)	238.08	--	--	--	--	--
Book Value Growth (%)	47.06	--	--	--	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	--	--	--	--	--	--
Price / Book Value	--	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.20	6.08	--	--	--	--
Close Price (₹)	--	--	--	--	--	--
High Price (₹)	--	--	--	--	--	--
Low Price (₹)	--	--	--	--	--	--
Market Cap (₹ Cr)	--	--	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.57	0.39	--	--	--	--
Short term debt to equity ratio	0.50	0.39	--	--	--	--
Current Ratio	1.81	2.08	--	--	--	--
Quick Ratio	1.12	1.34	--	--	--	--
Interest Coverage	9.52	14.80	--	--	--	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	33.90	58.12	--	--	--	--
Asset Turnover	2.01	0.99	--	--	--	--
Receivable days	99.51	212.12	--	--	--	--
Inventory Days	66.67	128.41	--	--	--	--
Payable days	56.07	95.77	--	--	--	--
Cash Conversion Cycle	110.11	244.77	--	--	--	--